Cargando…

Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy

BACKGROUND: The bacterial and metabolic networks in immunoglobin A nephropathy (IgAN), the most common type of primary chronic glomerulonephritis worldwide, have not been extensively studied. To help develop better methods for the diagnosis, treatment, and prognosis of IgAN, we characterized the alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shishi, Ma, Chiyu, Yang, Yan, Cai, Wanxia, Dai, Weier, Zhang, Xinzhou, Yin, Lianghong, Tang, Donge, Liu, Fanna, Dai, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761118/
https://www.ncbi.nlm.nih.gov/pubmed/36544661
http://dx.doi.org/10.21037/atm-22-5334
_version_ 1784852637875699712
author Li, Shishi
Ma, Chiyu
Yang, Yan
Cai, Wanxia
Dai, Weier
Zhang, Xinzhou
Yin, Lianghong
Tang, Donge
Liu, Fanna
Dai, Yong
author_facet Li, Shishi
Ma, Chiyu
Yang, Yan
Cai, Wanxia
Dai, Weier
Zhang, Xinzhou
Yin, Lianghong
Tang, Donge
Liu, Fanna
Dai, Yong
author_sort Li, Shishi
collection PubMed
description BACKGROUND: The bacterial and metabolic networks in immunoglobin A nephropathy (IgAN), the most common type of primary chronic glomerulonephritis worldwide, have not been extensively studied. To help develop better methods for the diagnosis, treatment, and prognosis of IgAN, we characterized the alterations of the urinary microbiome and serum metabolome in patients with IgAN. METHODS: We analyzed serum and urine samples from Chinese patients with IgAN and healthy controls (HCs) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and 16S ribosomal RNA gene sequencing. RESULTS: Patients with IgAN had a higher relative abundance of Actinomyces and a lower relative abundance of Lactobacillus. The elements of metabolism have been affected, including free amino acids, polyunsaturated fatty acids, and oligopeptides. We also identified the 9 metabolites that might be the core metabolites, including guanidinoacetic acid, apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)], and diethanolamine, which linked the metabolic networks between the urinary tract (UT) and blood. Other core metabolites, such as homocitrulline, apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)], butyrylcarnitine, formiminoglutamic acid (FIGLU), diethanolamine, and prolylhydroxyproline, were positively correlated with urinary mili-total protein (MTP). Conversely, Lactobacillus was negatively correlated with MTP. CONCLUSIONS: We verified the connection between the disruption of the microbiota and serum metabolites, along with the clinical parameters, in patients with IgAN, which may help provide a tool for IgAN interventions.
format Online
Article
Text
id pubmed-9761118
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-97611182022-12-20 Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy Li, Shishi Ma, Chiyu Yang, Yan Cai, Wanxia Dai, Weier Zhang, Xinzhou Yin, Lianghong Tang, Donge Liu, Fanna Dai, Yong Ann Transl Med Original Article BACKGROUND: The bacterial and metabolic networks in immunoglobin A nephropathy (IgAN), the most common type of primary chronic glomerulonephritis worldwide, have not been extensively studied. To help develop better methods for the diagnosis, treatment, and prognosis of IgAN, we characterized the alterations of the urinary microbiome and serum metabolome in patients with IgAN. METHODS: We analyzed serum and urine samples from Chinese patients with IgAN and healthy controls (HCs) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and 16S ribosomal RNA gene sequencing. RESULTS: Patients with IgAN had a higher relative abundance of Actinomyces and a lower relative abundance of Lactobacillus. The elements of metabolism have been affected, including free amino acids, polyunsaturated fatty acids, and oligopeptides. We also identified the 9 metabolites that might be the core metabolites, including guanidinoacetic acid, apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)], and diethanolamine, which linked the metabolic networks between the urinary tract (UT) and blood. Other core metabolites, such as homocitrulline, apo-[3-methylcrotonoyl-CoA:carbon-dioxide ligase (ADP-forming)], butyrylcarnitine, formiminoglutamic acid (FIGLU), diethanolamine, and prolylhydroxyproline, were positively correlated with urinary mili-total protein (MTP). Conversely, Lactobacillus was negatively correlated with MTP. CONCLUSIONS: We verified the connection between the disruption of the microbiota and serum metabolites, along with the clinical parameters, in patients with IgAN, which may help provide a tool for IgAN interventions. AME Publishing Company 2022-11 /pmc/articles/PMC9761118/ /pubmed/36544661 http://dx.doi.org/10.21037/atm-22-5334 Text en 2022 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Li, Shishi
Ma, Chiyu
Yang, Yan
Cai, Wanxia
Dai, Weier
Zhang, Xinzhou
Yin, Lianghong
Tang, Donge
Liu, Fanna
Dai, Yong
Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
title Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
title_full Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
title_fullStr Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
title_full_unstemmed Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
title_short Microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in Chinese patients with immunoglobulin A nephropathy
title_sort microbiome and metabolome analysis to clarify the interaction between the urine microbiota and serum metabolites in chinese patients with immunoglobulin a nephropathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761118/
https://www.ncbi.nlm.nih.gov/pubmed/36544661
http://dx.doi.org/10.21037/atm-22-5334
work_keys_str_mv AT lishishi microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT machiyu microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT yangyan microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT caiwanxia microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT daiweier microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT zhangxinzhou microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT yinlianghong microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT tangdonge microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT liufanna microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy
AT daiyong microbiomeandmetabolomeanalysistoclarifytheinteractionbetweentheurinemicrobiotaandserummetabolitesinchinesepatientswithimmunoglobulinanephropathy